scispace - formally typeset
Open AccessJournal ArticleDOI

Cannabis sativa: The Plant of the Thousand and One Molecules

TLDR
Prospects on the benefits linked to the use of the -omics technologies, such as metabolomics and transcriptomics to speed up the identification and the large-scale production of lead agents from bioengineered Cannabis cell culture, are presented.
Abstract
Cannabis sativa L. is an important herbaceous species originating from Central Asia, which has been used in folk medicine and as a source of textile fiber since the dawn of times. This fast-growing plant has recently seen a resurgence of interest because of its multi-purpose applications: it is indeed a treasure trove of phytochemicals and a rich source of both cellulosic and woody fibers. Equally highly interested in this plant are the pharmaceutical and construction sectors, since its metabolites show potent bioactivities on human health and its outer and inner stem tissues can be used to make bioplastics and concrete-like material, respectively. In this review, the rich spectrum of hemp phytochemicals is discussed by putting a special emphasis on molecules of industrial interest, including cannabinoids, terpenes and phenolic compounds, and their biosynthetic routes. Cannabinoids represent the most studied group of compounds, mainly due to their wide range of pharmaceutical effects in humans, including psychotropic activities. The therapeutic and commercial interests of some terpenes and phenolic compounds, and in particular stilbenoids and lignans, are also highlighted in view of the most recent literature data. Biotechnological avenues to enhance the production and bioactivity of hemp secondary metabolites are proposed by discussing the power of plant genetic engineering and tissue culture. In particular two systems are reviewed, i.e., cell suspension and hairy root cultures. Additionally, an entire section is devoted to hemp trichomes, in the light of their importance as phytochemical factories. Ultimately, prospects on the benefits linked to the use of the -omics technologies, such as metabolomics and transcriptomics to speed up the identification and the large-scale production of lead agents from bioengineered Cannabis cell culture, are presented.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Bipolar disorder and the endocannabinoid system

TL;DR: It is suggested that activation of CB2 may stabilise mood in this disorder and basic and clinical studies to determine how cannabis and cannabinoids (CBs) can affect mood are encouraged.
Journal ArticleDOI

Technology and characterisation of whole hemp seed beverages prepared from ultrasonicated and fermented whole seed paste

TL;DR: In this article, the authors applied fermentation with Pediococcus acidilactici LUHS29, P. pentosaceus LUHS183, Lactobacillus casei and L.uvarum LUHS245 strains, as well as ultrasonication (US) for whole hemp seed paste treatment and preparation of emulsions (HSE).
Journal ArticleDOI

Medical cannabis and cannabinoids in rheumatology: where are we now?

TL;DR: Clinicians involved in pain management can finally include cannabis or cannabis-related products in their therapeutic armamentarium as a growing number of countries have approved them for pain relief.
Journal ArticleDOI

Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions

TL;DR: The present study focuses on the main common points and potential interactions between kynurenines and the ECS in schizophrenia, which include the regulation of glutamatergic/dopaminergic/γ-aminobutyric acidergic neurotransmission, their presence in astrocytes, and their role in inflammatory mechanisms.
Journal ArticleDOI

Microwave-assisted extraction of phenolic compounds from Cannabis sativa L.: optimization and kinetics study

TL;DR: In this article, RSM and ANN were evaluated for prediction of physical and chemical properties of industrial hemp extracts prepared using MAE and the effects of liquid to solid ratio, ethanol content, extraction time, etc.
References
More filters
Journal ArticleDOI

Natural Products as Sources of New Drugs over the Last 25 Years

TL;DR: This review is an updated and expanded version of two prior reviews that were published in this journal in 1997 and 2003 and is able to identify only one de novo combinatorial compound approved as a drug in this 25 plus year time frame.
Journal ArticleDOI

Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010

TL;DR: This review is an updated and expanded version of the three prior reviews and adds a new designation, "natural product botanical" or "NB", to cover those botanical "defined mixtures" that have now been recognized as drug entities by the FDA and similar organizations.
Journal ArticleDOI

In vitro: Response of plant growth regulators and antimalformins on conidia germination of Fusarium mangiferae and incidence of mango malformation

TL;DR: The present findings do not authenticate the involvement of F. mangiferae in the disease, however hormonal imbalance, most probably ethylene, might be responsible for deformed functional morphology of panicle and a signal transduction mechanism of stress-stimulated ethylene imbalance causing physio-morphological changes in reproductive organs of mango flower and thereby failure of fertilization and fruit set needs to be investigated.
Journal ArticleDOI

Adverse Health Effects of Marijuana Use

TL;DR: As marijuana use becomes legal in some states, the dominant public opinion is that marijuana is a harmless source of mood alteration, but enough information is available to cause concern.
Journal ArticleDOI

The Endocannabinoid System as an Emerging Target of Pharmacotherapy

TL;DR: A comprehensive overview on the current state of knowledge of the endocannabinoid system as a target of pharmacotherapy is provided.
Related Papers (5)